0.11 0 (0%) | 09-13 12:32 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 0.14 | 1-year : | 0.17 |
Resists | First : | 0.12 | Second : | 0.15 |
Pivot price | 0.11 | |||
Supports | First : | 0.09 | Second : | 0.07 |
MAs | MA(5) : | 0.11 | MA(20) : | 0.11 |
MA(100) : | 0.12 | MA(250) : | 0.19 | |
MACD | MACD : | -0.1 | Signal : | -0.1 |
%K %D | K(14,3) : | 0 | D(3) : | 8.3 |
RSI | RSI(14): 47.7 | |||
52-week | High : | 0.5 | Low : | 0.05 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ RIBT ] has closed above bottom band by 37.5%. Bollinger Bands are 71% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.
If tomorrow: | Open lower | Open higher |
High: | 0.11 - 0.11 | 0.11 - 0.11 |
Low: | 0.11 - 0.11 | 0.11 - 0.11 |
Close: | 0.11 - 0.11 | 0.11 - 0.11 |
RiceBran Technologies, together with its subsidiaries, operates as a specialty ingredient company. It focuses on producing, processing, and marketing of value-added healthy, natural, and nutrient dense products derived from rice and other small grains. The company converts raw rice bran into stabilized rice bran (SRB) and high value derivative products, including RiBalance, a complete rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious carbohydrate and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich insoluble derivative of RiBalance; and ProRyza products, which includes derivatives composed of protein and protein/fiber blends. Its SRB and derivative products are nutritional and beneficial food products that contain a combination of oil, protein, carbohydrates, vitamins, minerals, fibers, and antioxidants that enhance the nutritional value of consumer products. The company's SRB products are also marketed as feed ingredients in the animal nutrition markets. It serves food and animal nutrition manufacturers, wholesalers, and retailers in the United States and internationally. The company was formerly known as NutraCea and changed its name to RiceBran Technologies in October 2012. RiceBran Technologies was founded in 2000 and is headquartered in Tomball, Texas.
Sat, 07 Sep 2024
RiceBran Technologies (NASDAQ:RIBT) Now Covered by StockNews.com - Defense World
Thu, 01 Feb 2024
RiceBran Technologies Sells Arkansas Facility Assets - TipRanks
Fri, 26 Jan 2024
RiceBran Technologies Sells Golden Ridge Milling Facility - StockTitan
Mon, 04 Dec 2023
RiceBran Technologies Secures Investment from Funicular Funds, LP - Yahoo Finance
Fri, 25 Aug 2023
Unmasking the Value Trap: A Comprehensive Analysis of RiceBran Technologies (RIBT) - Yahoo Finance
Mon, 26 Jun 2023
RiceBran Technologies Sells SRB Business - Yahoo Finance
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
NASDAQ
|
|
Sector:
Consumer Defensive
|
|
Industry:
Packaged Foods
|
|
Shares Out | 10 (M) |
Shares Float | 7 (M) |
Held by Insiders | 4.9 (%) |
Held by Institutions | 22.2 (%) |
Shares Short | 80 (K) |
Shares Short P.Month | 115 (K) |
EPS | -1.2 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | -0.48 |
Profit Margin | -76.3 % |
Operating Margin | -56.5 % |
Return on Assets (ttm) | -25.3 % |
Return on Equity (ttm) | -272.9 % |
Qtrly Rev. Growth | 8.5 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 2.28 |
EBITDA (p.s.) | -0.53 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | -4 (M) |
Levered Free Cash Flow | 1 (M) |
PE Ratio | -0.1 |
PEG Ratio | 0 |
Price to Book value | -0.23 |
Price to Sales | 0.04 |
Price to Cash Flow | -0.3 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |